-
Something wrong with this record ?
Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant
D. Yamasoba, K. Uriu, A. Plianchaisuk, Y. Kosugi, L. Pan, J. Zahradnik, Genotype to Phenotype Japan (G2P-Japan) Consortium, J. Ito, K. Sato
Language English Country United States
Document type Letter
NLK
ProQuest Central
from 2001-08-01 to 2 months ago
Nursing & Allied Health Database (ProQuest)
from 2001-08-01 to 2 months ago
Health & Medicine (ProQuest)
from 2001-08-01 to 2 months ago
Public Health Database (ProQuest)
from 2001-08-01 to 2 months ago
- MeSH
- COVID-19 * MeSH
- Humans MeSH
- SARS-CoV-2 * genetics MeSH
- Check Tag
- Humans MeSH
- Publication type
- Letter MeSH
1st Medical Faculty at Biocev Charles University Vestec Prague Czechia
CREST Japan Science and Technology Agency Kawaguchi Japan
Faculty of Medicine Kobe University Kobe Japan
Graduate School of Frontier Sciences The University of Tokyo Kashiwa Japan
International Research Center for Infectious Diseases The University of Tokyo Tokyo Japan
International Vaccine Design Center The University of Tokyo Tokyo Japan
The Institute of Medical Science and Graduate School of Medicine The University of Tokyo Tokyo Japan
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23011179
- 003
- CZ-PrNML
- 005
- 20230801132843.0
- 007
- ta
- 008
- 230718s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/S1473-3099(23)00278-5 $2 doi
- 035 __
- $a (PubMed)37148902
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Yamasoba, Daichi $u Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; Faculty of Medicine, Kobe University, Kobe, Japan
- 245 10
- $a Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant / $c D. Yamasoba, K. Uriu, A. Plianchaisuk, Y. Kosugi, L. Pan, J. Zahradnik, Genotype to Phenotype Japan (G2P-Japan) Consortium, J. Ito, K. Sato
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a SARS-CoV-2 $x genetika $7 D000086402
- 650 12
- $a COVID-19 $7 D000086382
- 655 _2
- $a dopisy $7 D016422
- 700 1_
- $a Uriu, Keiya $u Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; The Institute of Medical Science, and Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
- 700 1_
- $a Plianchaisuk, Arnon $u Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan
- 700 1_
- $a Kosugi, Yusuke $u Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; The Institute of Medical Science, and Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
- 700 1_
- $a Pan, Lin $u Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan
- 700 1_
- $a Zahradnik, Jiri $u First Medical Faculty at Biocev, Charles University, Vestec-Prague, Czechia
- 700 1_
- $a Ito, Jumpei $u Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; International Research Center for Infectious Diseases, The University of Tokyo, Tokyo, Japan
- 700 1_
- $a Sato, Kei $u Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; International Research Center for Infectious Diseases, The University of Tokyo, Tokyo, Japan; International Vaccine Design Center, The University of Tokyo, Tokyo, Japan; The Institute of Medical Science, and Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan; Collaboration Unit for Infection, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan; CREST, Japan Science and Technology Agency, Kawaguchi, Japan. Electronic address: keisato@g.ecc.u-tokyo.ac.jp
- 710 2_
- $a Genotype to Phenotype Japan (G2P-Japan) Consortium
- 773 0_
- $w MED00006437 $t The Lancet. Infectious diseases $x 1474-4457 $g Roč. 23, č. 6 (2023), s. 655-656
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37148902 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801132839 $b ABA008
- 999 __
- $a ok $b bmc $g 1963520 $s 1197444
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 23 $c 6 $d 655-656 $e 20230503 $i 1474-4457 $m Lancet. Infectious diseases $n Lancet Infect Dis $x MED00006437
- LZP __
- $a Pubmed-20230718
